Skip to main content
Premium Trial:

Request an Annual Quote

CancerGuide Diagnostics Raises $10.5M, Inks Deal with LabCorp

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CancerGuide Diagnostics, a molecular diagnostics startup based in Durham, NC, has raised $10.5 million through the first tranche of a private financing and has inked a collaboration with Laboratory Corporation of America.

The firm, which is led by former LabCorp CSO and CMO Myla Lai-Goldman, is actively seeking partnerships with startups that need help getting their molecular oncology diagnostic products to market. It also offers companion diagnostic test development and tumor biology profiling services to the pharmaceutical and biotechnology industries.

The financing round was co-led by Hatteras Venture Partners and Intersouth Partners. LabCorp also took an undisclosed stake in the company.

Under the agreement with LabCorp, the firms will collaborate in the development and commercialization of CancerGuide's molecular oncology assays. Further details of the alliance were not disclosed.

"Through our unique partnership model, CancerGuide will provide companion diagnostic development services to pharmaceutical and biotechnology companies to maximize the efficiency and effectiveness of the market entry strategies," CancerGuide CEO Lai-Goldman said in a statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.